TP53 and acute myeloid leukemia: Susceptibility to the p53 activator APR-246 was comparable in all AML cell lines with elevated susceptibility in the TP53 wild type ML-2 and the TP53 mutant MOLM-16 cells indicating a p53 independent mechanism of action.